Table 1 Patient demographics and clinical characteristics according to the physician (consecutive sample)*
From: The chronic rhinosinusitis with nasal polyp patient journey in the United States and Europe
|  | USA (n = 251) | EUR5 (n = 820) |
|---|---|---|
Age, years, mean (SD) | 45.1 (16.8) | 44.8 (14.7) |
Sex, n (%) | Â | Â |
Male | 147 (58.6) | 474 (57.8) |
Female | 104 (41.4) | 346 (42.2) |
Smoking status, n (%) | Â | Â |
Non-smoker | 183 (72.9) | 417 (50.9) |
Current smoker | 15 (6.0) | 142 (17.3) |
Former smoker | 42 (16.7) | 199 (24.3) |
Unknown | 11 (4.4) | 62 (7.6) |
Most common comorbidities, n (%) | Â | Â |
Allergic rhinitis | 165 (65.7) | 349 (42.6) |
Asthma | 124 (49.4) | 314 (38.3) |
Hypertension | 54 (21.5) | 139 (17.0) |
Charlson comorbidity index, mean (SD) | 0.12 (0.4) | 0.19 (0.7) |
Number of visits for CRSwNP in last 12 months, mean (SD) | 3.7 (2.8) | 4.0 (3.1) |
Nasal polyp score before treatment (scale 0–8), mean (SD) | n = 198 4.9 (2.2) | n = 742 4.7 (1.9) |
Physician-perceived severity before initiation of treatment for nasal polyps, n (%) | Â | Â |
Mild | 6 (2.4) | 28 (3.4) |
Moderate | 95 (37.8) | 423 (51.6) |
Severe | 111 (44.2) | 345 (42.1) |
Don’t know | 39 (15.5) | 24 (2.9) |